U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C9H11ClN4O2
Molecular Weight 242.662
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of TIPIRACIL

SMILES

ClC1=C(CN2CCCC2=N)NC(=O)NC1=O

InChI

InChIKey=QQHMKNYGKVVGCZ-UHFFFAOYSA-N
InChI=1S/C9H11ClN4O2/c10-7-5(12-9(16)13-8(7)15)4-14-3-1-2-6(14)11/h11H,1-4H2,(H2,12,13,15,16)

HIDE SMILES / InChI

Molecular Formula C9H11ClN4O2
Molecular Weight 242.662
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

Substance Class Chemical
Created
by admin
on Sat Dec 16 01:41:50 UTC 2023
Edited
by admin
on Sat Dec 16 01:41:50 UTC 2023
Record UNII
NGO10K751P
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
TIPIRACIL
DASH   INN   USAN   WHO-DD  
USAN   INN  
Official Name English
TPI (FREEBASE)
Code English
TIPIRACIL [USAN]
Common Name English
tipiracil [INN]
Common Name English
TIPIRACIL [MI]
Common Name English
5-Chloro-6-[(2-iminopyrrolidin-1-yl)methyl]pyrimidine-2,4-(1H,3H)-dione
Common Name English
Tipiracil [WHO-DD]
Common Name English
MA-1
Code English
Classification Tree Code System Code
FDA ORPHAN DRUG 564116
Created by admin on Sat Dec 16 01:41:50 UTC 2023 , Edited by admin on Sat Dec 16 01:41:50 UTC 2023
NCI_THESAURUS C129825
Created by admin on Sat Dec 16 01:41:50 UTC 2023 , Edited by admin on Sat Dec 16 01:41:50 UTC 2023
NDF-RT N0000191870
Created by admin on Sat Dec 16 01:41:50 UTC 2023 , Edited by admin on Sat Dec 16 01:41:50 UTC 2023
Code System Code Type Description
FDA UNII
NGO10K751P
Created by admin on Sat Dec 16 01:41:50 UTC 2023 , Edited by admin on Sat Dec 16 01:41:50 UTC 2023
PRIMARY
IUPHAR
8696
Created by admin on Sat Dec 16 01:41:50 UTC 2023 , Edited by admin on Sat Dec 16 01:41:50 UTC 2023
PRIMARY
CAS
183204-74-2
Created by admin on Sat Dec 16 01:41:50 UTC 2023 , Edited by admin on Sat Dec 16 01:41:50 UTC 2023
PRIMARY
ChEMBL
CHEMBL235668
Created by admin on Sat Dec 16 01:41:50 UTC 2023 , Edited by admin on Sat Dec 16 01:41:50 UTC 2023
PRIMARY
NCI_THESAURUS
C152646
Created by admin on Sat Dec 16 01:41:50 UTC 2023 , Edited by admin on Sat Dec 16 01:41:50 UTC 2023
PRIMARY
DRUG CENTRAL
4893
Created by admin on Sat Dec 16 01:41:50 UTC 2023 , Edited by admin on Sat Dec 16 01:41:50 UTC 2023
PRIMARY
DRUG BANK
DB09343
Created by admin on Sat Dec 16 01:41:50 UTC 2023 , Edited by admin on Sat Dec 16 01:41:50 UTC 2023
PRIMARY
NDF-RT
N0000191869
Created by admin on Sat Dec 16 01:41:50 UTC 2023 , Edited by admin on Sat Dec 16 01:41:50 UTC 2023
PRIMARY Thymidine Phosphorylase Inhibitors [MoA]
DAILYMED
NGO10K751P
Created by admin on Sat Dec 16 01:41:50 UTC 2023 , Edited by admin on Sat Dec 16 01:41:50 UTC 2023
PRIMARY
EPA CompTox
DTXSID601025833
Created by admin on Sat Dec 16 01:41:50 UTC 2023 , Edited by admin on Sat Dec 16 01:41:50 UTC 2023
PRIMARY
RXCUI
1670304
Created by admin on Sat Dec 16 01:41:50 UTC 2023 , Edited by admin on Sat Dec 16 01:41:50 UTC 2023
PRIMARY RxNorm
CHEBI
90879
Created by admin on Sat Dec 16 01:41:50 UTC 2023 , Edited by admin on Sat Dec 16 01:41:50 UTC 2023
PRIMARY
EVMPD
SUB174128
Created by admin on Sat Dec 16 01:41:50 UTC 2023 , Edited by admin on Sat Dec 16 01:41:50 UTC 2023
PRIMARY
WIKIPEDIA
Tipiracil
Created by admin on Sat Dec 16 01:41:50 UTC 2023 , Edited by admin on Sat Dec 16 01:41:50 UTC 2023
PRIMARY
PUBCHEM
6323266
Created by admin on Sat Dec 16 01:41:50 UTC 2023 , Edited by admin on Sat Dec 16 01:41:50 UTC 2023
PRIMARY
SMS_ID
100000160943
Created by admin on Sat Dec 16 01:41:50 UTC 2023 , Edited by admin on Sat Dec 16 01:41:50 UTC 2023
PRIMARY
INN
9500
Created by admin on Sat Dec 16 01:41:50 UTC 2023 , Edited by admin on Sat Dec 16 01:41:50 UTC 2023
PRIMARY
USAN
BC-15
Created by admin on Sat Dec 16 01:41:50 UTC 2023 , Edited by admin on Sat Dec 16 01:41:50 UTC 2023
PRIMARY
MERCK INDEX
m11862
Created by admin on Sat Dec 16 01:41:50 UTC 2023 , Edited by admin on Sat Dec 16 01:41:50 UTC 2023
PRIMARY
Related Record Type Details
SALT/SOLVATE -> PARENT
TARGET -> INHIBITOR
BINDER->LIGAND
The in vitro protein binding in human plasma is below 8% for tipiracil.
BINDING
EXCRETED UNCHANGED
URINE
Related Record Type Details
METABOLITE -> PARENT
Related Record Type Details
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Volume of Distribution PHARMACOKINETIC SINGLE DOSE ADMINISTRATION

Biological Half-life PHARMACOKINETIC SINGLE DOSE ADMINISTRATION